| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuins | 17 | 2021 | 74 | 5.990 |
Why?
|
| Cardiomegaly | 18 | 2021 | 121 | 4.630 |
Why?
|
| Myocytes, Cardiac | 20 | 2021 | 317 | 3.890 |
Why?
|
| Sirtuin 3 | 13 | 2019 | 37 | 3.790 |
Why?
|
| Myocardium | 21 | 2017 | 586 | 3.150 |
Why?
|
| Histone Deacetylases | 8 | 2015 | 86 | 1.920 |
Why?
|
| Myosin Heavy Chains | 6 | 2015 | 91 | 1.590 |
Why?
|
| Mitochondria, Heart | 4 | 2019 | 52 | 1.530 |
Why?
|
| Aging | 3 | 2021 | 738 | 1.160 |
Why?
|
| Acetylation | 14 | 2018 | 146 | 1.110 |
Why?
|
| Cells, Cultured | 28 | 2017 | 2902 | 1.110 |
Why?
|
| Sirtuin 1 | 7 | 2016 | 36 | 1.110 |
Why?
|
| Animals | 58 | 2021 | 28003 | 1.040 |
Why?
|
| Lignans | 2 | 2017 | 6 | 1.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 4 | 2009 | 54 | 1.030 |
Why?
|
| Biphenyl Compounds | 3 | 2017 | 61 | 1.030 |
Why?
|
| Oxidative Stress | 10 | 2019 | 466 | 1.020 |
Why?
|
| Doxorubicin | 2 | 2017 | 296 | 0.980 |
Why?
|
| Serum Response Factor | 8 | 2010 | 45 | 0.930 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 252 | 0.930 |
Why?
|
| Rats | 23 | 2019 | 4067 | 0.910 |
Why?
|
| Mice | 29 | 2021 | 12110 | 0.880 |
Why?
|
| DNA-Binding Proteins | 8 | 2012 | 1247 | 0.870 |
Why?
|
| Cardiomyopathies | 2 | 2017 | 272 | 0.860 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2018 | 403 | 0.820 |
Why?
|
| Fibroblasts | 6 | 2016 | 767 | 0.780 |
Why?
|
| Sarcomeres | 3 | 2015 | 27 | 0.780 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2014 | 364 | 0.770 |
Why?
|
| Mice, Knockout | 15 | 2018 | 2087 | 0.770 |
Why?
|
| Signal Transduction | 15 | 2019 | 3508 | 0.740 |
Why?
|
| Mitochondria | 3 | 2015 | 599 | 0.740 |
Why?
|
| Myofibroblasts | 3 | 2016 | 50 | 0.710 |
Why?
|
| Mitochondrial Proteins | 4 | 2017 | 129 | 0.710 |
Why?
|
| DNA Damage | 3 | 2021 | 381 | 0.700 |
Why?
|
| Muscular Atrophy | 2 | 2019 | 46 | 0.700 |
Why?
|
| Cardiac Myosins | 3 | 2012 | 19 | 0.660 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2018 | 72 | 0.660 |
Why?
|
| Immune System | 1 | 2020 | 102 | 0.650 |
Why?
|
| Up-Regulation | 4 | 2017 | 731 | 0.650 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2019 | 4 | 0.650 |
Why?
|
| Heart Failure | 7 | 2012 | 1346 | 0.640 |
Why?
|
| Cachexia | 1 | 2019 | 13 | 0.630 |
Why?
|
| NAD | 6 | 2011 | 92 | 0.610 |
Why?
|
| DNA, Mitochondrial | 2 | 2016 | 189 | 0.600 |
Why?
|
| Heart | 4 | 2016 | 584 | 0.590 |
Why?
|
| Ventricular Remodeling | 3 | 2015 | 109 | 0.590 |
Why?
|
| Reactive Oxygen Species | 8 | 2017 | 505 | 0.580 |
Why?
|
| Myostatin | 1 | 2017 | 3 | 0.570 |
Why?
|
| Enzyme Activation | 7 | 2016 | 698 | 0.550 |
Why?
|
| Mitochondrial Dynamics | 2 | 2017 | 56 | 0.540 |
Why?
|
| Cell Survival | 6 | 2014 | 1008 | 0.520 |
Why?
|
| Endothelial Cells | 3 | 2008 | 475 | 0.500 |
Why?
|
| Cell Nucleus | 7 | 2020 | 612 | 0.500 |
Why?
|
| Protein Binding | 11 | 2019 | 1513 | 0.490 |
Why?
|
| Cell Death | 7 | 2016 | 261 | 0.480 |
Why?
|
| Cold Temperature | 4 | 2011 | 161 | 0.480 |
Why?
|
| Angiotensin II | 3 | 2017 | 93 | 0.470 |
Why?
|
| Obesity | 2 | 2019 | 1016 | 0.460 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 92 | 0.450 |
Why?
|
| GTP Phosphohydrolases | 2 | 2017 | 76 | 0.450 |
Why?
|
| HeLa Cells | 6 | 2013 | 514 | 0.450 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2006 | 221 | 0.450 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2012 | 112 | 0.440 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 474 | 0.440 |
Why?
|
| Transcription Factors | 6 | 2007 | 1684 | 0.440 |
Why?
|
| Heart Diseases | 3 | 2017 | 308 | 0.440 |
Why?
|
| Gene Expression Regulation | 10 | 2015 | 2004 | 0.430 |
Why?
|
| MicroRNAs | 5 | 2025 | 575 | 0.430 |
Why?
|
| Mice, Transgenic | 6 | 2013 | 1589 | 0.410 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2012 | 9 | 0.410 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 126 | 0.410 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 21 | 0.400 |
Why?
|
| Phosphorylation | 8 | 2018 | 1142 | 0.390 |
Why?
|
| p300-CBP Transcription Factors | 2 | 2011 | 29 | 0.380 |
Why?
|
| Ferritins | 2 | 2008 | 30 | 0.370 |
Why?
|
| Actin Cytoskeleton | 2 | 2010 | 199 | 0.370 |
Why?
|
| Protein Isoforms | 6 | 2018 | 283 | 0.370 |
Why?
|
| RNA, Messenger | 5 | 2025 | 2037 | 0.320 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 68 | 0.320 |
Why?
|
| Iron | 2 | 2008 | 174 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 462 | 0.300 |
Why?
|
| Ischemic Preconditioning | 1 | 2008 | 37 | 0.300 |
Why?
|
| Antigens, Nuclear | 1 | 2008 | 25 | 0.300 |
Why?
|
| Fibrosis | 4 | 2016 | 239 | 0.300 |
Why?
|
| Hydroxamic Acids | 2 | 2008 | 50 | 0.300 |
Why?
|
| Blotting, Western | 6 | 2013 | 795 | 0.300 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2008 | 59 | 0.300 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 177 | 0.290 |
Why?
|
| Cell Membrane | 1 | 2011 | 684 | 0.290 |
Why?
|
| Humans | 30 | 2025 | 92337 | 0.290 |
Why?
|
| Hypothermia, Induced | 1 | 2008 | 83 | 0.290 |
Why?
|
| Fructose | 1 | 2008 | 36 | 0.290 |
Why?
|
| Nuclear Proteins | 3 | 2002 | 734 | 0.290 |
Why?
|
| Sirtuin 2 | 2 | 2018 | 30 | 0.280 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2016 | 89 | 0.260 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 43 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2016 | 1235 | 0.250 |
Why?
|
| Tissue Preservation | 1 | 2006 | 15 | 0.250 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 652 | 0.240 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2025 | 3 | 0.240 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2025 | 2 | 0.240 |
Why?
|
| Transfection | 5 | 2008 | 901 | 0.240 |
Why?
|
| Tubulin | 1 | 2004 | 60 | 0.230 |
Why?
|
| Phenylephrine | 3 | 2015 | 36 | 0.230 |
Why?
|
| Animals, Newborn | 3 | 2012 | 524 | 0.220 |
Why?
|
| Energy Metabolism | 2 | 2020 | 302 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 4 | 2012 | 968 | 0.220 |
Why?
|
| Repressor Proteins | 2 | 2007 | 434 | 0.220 |
Why?
|
| Isoenzymes | 3 | 2015 | 277 | 0.210 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 68 | 0.210 |
Why?
|
| Base Sequence | 7 | 2012 | 2317 | 0.210 |
Why?
|
| DNA, Single-Stranded | 1 | 2003 | 93 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2003 | 86 | 0.200 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2014 | 15 | 0.200 |
Why?
|
| Superoxide Dismutase | 3 | 2015 | 155 | 0.200 |
Why?
|
| Antioxidants | 4 | 2009 | 224 | 0.200 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 115 | 0.200 |
Why?
|
| COS Cells | 4 | 2009 | 167 | 0.200 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 158 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 2669 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2448 | 0.190 |
Why?
|
| Endomyocardial Fibrosis | 2 | 2014 | 6 | 0.180 |
Why?
|
| Telomere Shortening | 1 | 2021 | 25 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 34 | 0.180 |
Why?
|
| HEK293 Cells | 3 | 2014 | 666 | 0.180 |
Why?
|
| Stress, Physiological | 3 | 2012 | 245 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2014 | 79 | 0.170 |
Why?
|
| Alternative Splicing | 1 | 2002 | 214 | 0.170 |
Why?
|
| Hypertrophy | 2 | 2011 | 67 | 0.170 |
Why?
|
| Apoptosis | 4 | 2018 | 1743 | 0.170 |
Why?
|
| Cell Line | 4 | 2019 | 2505 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2015 | 680 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 95 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 109 | 0.170 |
Why?
|
| Muscle Proteins | 2 | 2013 | 132 | 0.170 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2012 | 71 | 0.160 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2019 | 2 | 0.160 |
Why?
|
| Stilbenes | 2 | 2011 | 25 | 0.160 |
Why?
|
| Gene Expression | 4 | 2014 | 1312 | 0.160 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2019 | 16 | 0.160 |
Why?
|
| Deoxyguanosine | 2 | 2016 | 28 | 0.160 |
Why?
|
| DNA Glycosylases | 2 | 2016 | 25 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1592 | 0.160 |
Why?
|
| Smad3 Protein | 2 | 2015 | 25 | 0.150 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2015 | 45 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3360 | 0.150 |
Why?
|
| Time Factors | 4 | 2016 | 5430 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 128 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2018 | 23 | 0.150 |
Why?
|
| Coronary Vessels | 2 | 2011 | 197 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1720 | 0.140 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 2 | 2009 | 26 | 0.140 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 9 | 0.140 |
Why?
|
| Heart Ventricles | 3 | 2015 | 795 | 0.140 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 3017 | 0.140 |
Why?
|
| Deferoxamine | 2 | 2008 | 18 | 0.140 |
Why?
|
| Activins | 1 | 2017 | 26 | 0.140 |
Why?
|
| Response Elements | 1 | 2017 | 65 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 4 | 2018 | 741 | 0.130 |
Why?
|
| Rabbits | 3 | 2012 | 644 | 0.130 |
Why?
|
| DNA Adducts | 1 | 2016 | 21 | 0.130 |
Why?
|
| DNA | 4 | 2016 | 1308 | 0.130 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 57 | 0.130 |
Why?
|
| Muscle Cells | 2 | 2006 | 18 | 0.130 |
Why?
|
| Bleomycin | 3 | 2016 | 103 | 0.130 |
Why?
|
| Hydrolysis | 1 | 2016 | 144 | 0.120 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 58 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2008 | 106 | 0.120 |
Why?
|
| Isoproterenol | 1 | 2015 | 62 | 0.120 |
Why?
|
| DNA Primers | 2 | 2009 | 542 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 80 | 0.120 |
Why?
|
| Peroxynitrous Acid | 1 | 2014 | 2 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 288 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2015 | 82 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2018 | 319 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 149 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 99 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2014 | 33 | 0.110 |
Why?
|
| Models, Biological | 4 | 2016 | 1786 | 0.110 |
Why?
|
| Calcium | 3 | 2012 | 1183 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 154 | 0.110 |
Why?
|
| Regeneration | 1 | 2015 | 158 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 559 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2017 | 470 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 2074 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 200 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 266 | 0.110 |
Why?
|
| Granulosa Cells | 1 | 2013 | 33 | 0.110 |
Why?
|
| Male | 10 | 2016 | 43925 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 250 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2012 | 228 | 0.110 |
Why?
|
| Luteinizing Hormone | 1 | 2013 | 167 | 0.110 |
Why?
|
| Cytoprotection | 2 | 2016 | 51 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2014 | 79 | 0.110 |
Why?
|
| Epidermal Growth Factor | 1 | 2013 | 118 | 0.110 |
Why?
|
| Arterioles | 1 | 2013 | 22 | 0.110 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 140 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2015 | 301 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2014 | 149 | 0.110 |
Why?
|
| Tissue Engineering | 1 | 2015 | 201 | 0.100 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 37 | 0.100 |
Why?
|
| Skin | 1 | 2016 | 594 | 0.100 |
Why?
|
| Tetrazolium Salts | 1 | 2012 | 12 | 0.100 |
Why?
|
| RNA Interference | 2 | 2016 | 384 | 0.100 |
Why?
|
| Leucine | 1 | 2012 | 59 | 0.100 |
Why?
|
| Glutathione | 2 | 2013 | 105 | 0.100 |
Why?
|
| Coloring Agents | 1 | 2012 | 65 | 0.100 |
Why?
|
| Plasmids | 2 | 2005 | 288 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2012 | 50 | 0.100 |
Why?
|
| DNA Probes | 2 | 2003 | 77 | 0.100 |
Why?
|
| Histone Demethylases | 1 | 2012 | 33 | 0.100 |
Why?
|
| Glutathione Transferase | 3 | 2002 | 112 | 0.100 |
Why?
|
| Liver | 2 | 2015 | 1228 | 0.100 |
Why?
|
| Thiazoles | 1 | 2012 | 128 | 0.100 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 45 | 0.100 |
Why?
|
| ras Proteins | 1 | 2013 | 133 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 410 | 0.090 |
Why?
|
| Kidney | 2 | 2015 | 1145 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 373 | 0.090 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 643 | 0.090 |
Why?
|
| Endothelium | 1 | 2011 | 60 | 0.090 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2011 | 5 | 0.090 |
Why?
|
| Catalase | 2 | 2009 | 49 | 0.090 |
Why?
|
| Enzyme Activators | 1 | 2011 | 14 | 0.090 |
Why?
|
| Acetyltransferases | 1 | 2011 | 36 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 78 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 198 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 1163 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 492 | 0.080 |
Why?
|
| RNA Stability | 2 | 2025 | 92 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2002 | 298 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 145 | 0.080 |
Why?
|
| Proteomics | 1 | 2011 | 246 | 0.080 |
Why?
|
| Lung | 1 | 2016 | 1337 | 0.080 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Female | 6 | 2019 | 47893 | 0.080 |
Why?
|
| Chromatin | 1 | 2012 | 417 | 0.080 |
Why?
|
| Binding Sites | 2 | 2003 | 1130 | 0.080 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 355 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 743 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 606 | 0.080 |
Why?
|
| Insulin | 1 | 2014 | 1167 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 322 | 0.080 |
Why?
|
| Heme Oxygenase-1 | 1 | 2008 | 22 | 0.080 |
Why?
|
| Ku Autoantigen | 1 | 2008 | 12 | 0.080 |
Why?
|
| Cattle | 2 | 2006 | 380 | 0.080 |
Why?
|
| Oxidation-Reduction | 3 | 2014 | 402 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 55 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1240 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1807 | 0.070 |
Why?
|
| Biological Assay | 1 | 2008 | 81 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 256 | 0.070 |
Why?
|
| Densitometry | 1 | 2008 | 28 | 0.070 |
Why?
|
| LIM Domain Proteins | 1 | 2008 | 25 | 0.070 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2008 | 27 | 0.070 |
Why?
|
| Antithyroid Agents | 1 | 2008 | 23 | 0.070 |
Why?
|
| Propylthiouracil | 1 | 2008 | 27 | 0.070 |
Why?
|
| Cell Size | 1 | 2008 | 71 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 66 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1091 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 668 | 0.070 |
Why?
|
| Echocardiography | 1 | 2012 | 968 | 0.070 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 420 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2007 | 73 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 164 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2007 | 295 | 0.070 |
Why?
|
| Protein Transport | 1 | 2008 | 430 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 108 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2006 | 28 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 891 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2006 | 41 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 173 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 46 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 115 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2018 | 272 | 0.060 |
Why?
|
| Catalysis | 1 | 2006 | 210 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2005 | 159 | 0.060 |
Why?
|
| Polyadenylation | 1 | 2025 | 12 | 0.060 |
Why?
|
| Mutation | 3 | 2011 | 4204 | 0.060 |
Why?
|
| Cardiac Volume | 1 | 2005 | 53 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2025 | 96 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 349 | 0.060 |
Why?
|
| Diet | 1 | 2008 | 448 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1212 | 0.060 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2004 | 57 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 72 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2002 | 110 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 122 | 0.060 |
Why?
|
| Caspases | 1 | 2004 | 158 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2006 | 909 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 298 | 0.060 |
Why?
|
| Aorta | 1 | 2005 | 291 | 0.060 |
Why?
|
| Microtubules | 1 | 2004 | 129 | 0.050 |
Why?
|
| RNA | 1 | 2008 | 589 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 561 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2003 | 24 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 146 | 0.050 |
Why?
|
| Striga | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 164 | 0.050 |
Why?
|
| Adult | 3 | 2016 | 27532 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2003 | 64 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2003 | 276 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 429 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 283 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 383 | 0.050 |
Why?
|
| Collodion | 1 | 2001 | 7 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 660 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 701 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 507 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2000 | 53 | 0.040 |
Why?
|
| Exons | 1 | 2002 | 453 | 0.040 |
Why?
|
| Hypertension | 1 | 2006 | 763 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2000 | 45 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 211 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 760 | 0.040 |
Why?
|
| Serine | 1 | 2000 | 105 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2002 | 190 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 358 | 0.040 |
Why?
|
| Fetus | 1 | 2000 | 234 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2013 | 242 | 0.040 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2018 | 14 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 64 | 0.040 |
Why?
|
| Kinetics | 1 | 2000 | 1550 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2018 | 58 | 0.040 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2018 | 66 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 281 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2018 | 160 | 0.030 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2016 | 14 | 0.030 |
Why?
|
| Dynamins | 1 | 2017 | 51 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2016 | 74 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 507 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 51 | 0.030 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2007 | 4 | 0.030 |
Why?
|
| MEF2 Transcription Factors | 2 | 2007 | 10 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2001 | 967 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2015 | 112 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2015 | 58 | 0.030 |
Why?
|
| Adenylate Kinase | 1 | 2014 | 13 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2014 | 88 | 0.030 |
Why?
|
| Actins | 2 | 2012 | 470 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2014 | 6 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 19 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 101 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 65 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Oncogenes | 1 | 2014 | 99 | 0.030 |
Why?
|
| Epidermis | 1 | 2014 | 102 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 105 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 152 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 282 | 0.030 |
Why?
|
| Buffaloes | 1 | 2013 | 1 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 67 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 196 | 0.030 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2013 | 6 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1336 | 0.030 |
Why?
|
| Isothiocyanates | 1 | 2013 | 7 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 299 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2013 | 6 | 0.030 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 2013 | 4 | 0.030 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2013 | 10 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 301 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 70 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2013 | 48 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2013 | 41 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 39 | 0.030 |
Why?
|
| Lysine | 1 | 2014 | 181 | 0.030 |
Why?
|
| Retina | 1 | 2014 | 225 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 222 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 236 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 332 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 276 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 19943 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 81 | 0.020 |
Why?
|
| Actomyosin | 1 | 2012 | 47 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 604 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 122 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2012 | 287 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 6916 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 342 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 146 | 0.020 |
Why?
|
| Glycolysis | 1 | 2011 | 184 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 145 | 0.020 |
Why?
|
| Child | 1 | 2002 | 7334 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 465 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 27030 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1850 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 307 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 441 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1310 | 0.020 |
Why?
|
| MADS Domain Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2007 | 13 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2007 | 23 | 0.020 |
Why?
|
| Mathematics | 1 | 2007 | 191 | 0.020 |
Why?
|
| Lipid Peroxides | 1 | 2006 | 11 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2006 | 33 | 0.020 |
Why?
|
| Hypoxia | 1 | 2012 | 672 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2006 | 29 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 98 | 0.020 |
Why?
|
| Introns | 1 | 2006 | 302 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2006 | 169 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2007 | 497 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2003 | 3 | 0.010 |
Why?
|
| Picrates | 1 | 2003 | 12 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 2003 | 26 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3509 | 0.010 |
Why?
|
| Free Radicals | 1 | 2003 | 70 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 60 | 0.010 |
Why?
|
| Solvents | 1 | 2003 | 90 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 56 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 305 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 129 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2003 | 283 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2003 | 245 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 262 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 1596 | 0.010 |
Why?
|